{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:29:02Z","timestamp":1771939742918,"version":"3.50.1"},"reference-count":220,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.2217\/pgs.10.171","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T17:43:41Z","timestamp":1298051021000},"page":"215-233","source":"Crossref","is-referenced-by-count":91,"title":["Absorption, Distribution, Metabolism and Excretion Pharmacogenomics of Drugs of Abuse"],"prefix":"10.1080","volume":"12","author":[{"given":"Markus R","family":"Meyer","sequence":"first","affiliation":[{"name":"Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Saarland University, D 66421Homburg (Saar), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Saarland University, D 66421Homburg (Saar), Germany"},{"name":"Tel.: Fax:"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20100522"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181e44244"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920010791636202"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250701882482"},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.56.082103.104724"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.6.889"},{"key":"e_1_3_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200054021834"},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.003236"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443140-00003"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0832-2"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020526"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00015"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A447"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-120001392"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.3.2.185"},{"key":"e_1_3_3_3_16_1","first-page":"181","article-title":"Polymorphism of cytochrome P450 and xenobiotic toxicity.","author":"Ingelman-Sundberg M","year":"2002","unstructured":"Ingelman-Sundberg M : Polymorphism of cytochrome P450 and xenobiotic toxicity.Toxicology181\u2013182, 447\u2013452 (2002).","journal-title":"Toxicology"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602530902843483"},{"key":"e_1_3_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318070-000000000-00000"},{"key":"e_1_3_3_3_19_1","article-title":"CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype\u2013phenotype association study design in translational pharmacogenetics.","author":"Suzuki Y","year":"2010","unstructured":"Suzuki Y , SugaiT, FukuiN et al.: CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype\u2013phenotype association study design in translational pharmacogenetics.J. Psychopharmacol. (2010) (Epub ahead of print).","journal-title":"J. Psychopharmacol."},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael173"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00019"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250110102674"},{"key":"e_1_3_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200002000-00028"},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200007000-00001"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161210790112674"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000028396"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/11317550-000000000-00000"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211812.27558.6e"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200204000-00009"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200054021825"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920010791526042"},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2000.11754319"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00020"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.250"},{"key":"e_1_3_3_3_35_1","unstructured":"Maurer HH : The relevance of pharmacogenetics and of metabolic interactions for clinical and forensic toxicology. In: Proceedings of the XIIIth GTFCh Symposium in Mosbach. Pragst F Aderjan R (Eds). Helm-Verlag Heppenheim Germany 197\u2013203 (2003)."},{"key":"e_1_3_3_3_36_1","unstructured":"Maurer HH : Toxicokinetics \u2013 variations due to genetics or interactions: basics and examples. In: Current Contributions to Forensic and Clinical Toxicology. Pragst F Aderjan R (Eds). GTFCH Bad Vilbel Germany 153\u2013155 (2008)."},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60750-7"},{"key":"e_1_3_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.10.47"},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2009.00668.x"},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199203000-00005"},{"key":"e_1_3_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.01.010"},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.4.447"},{"key":"e_1_3_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31819faa54"},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00709.x"},{"key":"e_1_3_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.11.030"},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-305X(92)90025-8"},{"key":"e_1_3_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.177"},{"key":"e_1_3_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00266a009"},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.012"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920008785821710"},{"key":"e_1_3_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.7.743"},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181642938"},{"key":"e_1_3_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256276"},{"key":"e_1_3_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1967.tb00029.x"},{"key":"e_1_3_3_3_56_1","first-page":"1072","article-title":"Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.","volume":"25","author":"Labroo RB","year":"1997","unstructured":"Labroo RB , PaineMF, ThummelKE, KharaschED: Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.Drug Metab. Dispos.25 , 1072\u20131080 (1997).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199303000-00030"},{"key":"e_1_3_3_3_58_1","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.","volume":"82","author":"Tateishi T","year":"1996","unstructured":"Tateishi T , KrivorukY, UengYF et al.: Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.Anesth. Analg.82 , 167\u2013172 (1996).","journal-title":"Anesth. Analg."},{"key":"e_1_3_3_3_59_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0090-9556(25)07486-0","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.","volume":"24","author":"Feierman DE","year":"1996","unstructured":"Feierman DE , LaskerJM: Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.Drug Metab. Dispos.24 , 932\u2013939 (1996).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100046"},{"key":"e_1_3_3_3_61_1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-3565(24)38239-4","article-title":"Active transport of fentanyl by the blood\u2013brain barrier.","volume":"289","author":"Henthorn TK","year":"1999","unstructured":"Henthorn TK , LiuY, MahapatroM, NgKY: Active transport of fentanyl by the blood\u2013brain barrier.J. Pharmacol. Exp. Ther.289 , 1084\u20131089 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e31818e0bd1"},{"key":"e_1_3_3_3_63_1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.","volume":"297","author":"Huang P","year":"2001","unstructured":"Huang P , KehnerGB, CowanA, Liu-ChenLY: Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.J. Pharmacol. Exp. Ther.297 , 688\u2013695 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00160-4"},{"key":"e_1_3_3_3_65_1","first-page":"818","article-title":"Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.","volume":"26","author":"Kobayashi K","year":"1998","unstructured":"Kobayashi K , YamamotoT, ChibaK et al.: Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.Drug Metab. Dispos.26 , 818\u2013821 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.003681"},{"key":"e_1_3_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1086\/508186"},{"key":"e_1_3_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.06.007"},{"key":"e_1_3_3_3_69_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0090-9556(25)07765-7","article-title":"The metabolism and excretion of buprenorphine in humans.","volume":"12","author":"Cone EJ","year":"1984","unstructured":"Cone EJ , GorodetzkyCW, YousefnejadD, BuchwaldWF, JohnsonRE: The metabolism and excretion of buprenorphine in humans.Drug Metab. Dispos.12 , 577\u2013581 (1984).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1996.0320"},{"key":"e_1_3_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.2174\/187231209788654117"},{"key":"e_1_3_3_3_72_1","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.","volume":"26","author":"Green MD","year":"1998","unstructured":"Green MD , KingCD, MojarrabiB, MackenziePI, TephlyTR: Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.Drug Metab. Dispos.26 , 507\u2013512 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.12.1364"},{"key":"e_1_3_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029546"},{"key":"e_1_3_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb12882.x"},{"key":"e_1_3_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb14226.x"},{"key":"e_1_3_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002100000266"},{"key":"e_1_3_3_3_78_1","first-page":"1146","article-title":"Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.","volume":"29","author":"Subrahmanyam V","year":"2001","unstructured":"Subrahmanyam V , RenwickAB, WaltersDG et al.: Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.Drug Metab. Dispos.29 , 1146\u20131155 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0135-x"},{"key":"e_1_3_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100152"},{"key":"e_1_3_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.1.1"},{"key":"e_1_3_3_3_82_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","article-title":"Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.","volume":"279","author":"Kamendulis LM","year":"1996","unstructured":"Kamendulis LM , BrzezinskiMR, PindelEV, BosronWF, DeanRA: Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.J. Pharmacol. Exp. Ther.279 , 713\u2013717 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsb919"},{"key":"e_1_3_3_3_84_1","first-page":"1089","article-title":"Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.","volume":"25","author":"Brzezinski MR","year":"1997","unstructured":"Brzezinski MR , SpinkBJ, DeanRA et al.: Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.Drug Metab. Dispos.25 , 1089\u20131096 (1997).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.20035"},{"key":"e_1_3_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.9.1086"},{"key":"e_1_3_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/0049825031000121608"},{"key":"e_1_3_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01866.x"},{"key":"e_1_3_3_3_89_1","article-title":"Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.","author":"Fujita KI","year":"2009","unstructured":"Fujita KI , AndoY, YamamotoW et al.: Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.Cancer Chemother. Pharmacol. (2009) (Epub ahead of print).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"e_1_3_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.212"},{"key":"e_1_3_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199710000-00010"},{"key":"e_1_3_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200008000-00008"},{"key":"e_1_3_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050247"},{"key":"e_1_3_3_3_94_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0090-9556(25)07426-4","article-title":"Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.","volume":"24","author":"Caraco Y","year":"1996","unstructured":"Caraco Y , TateishiT, GuengerichFP, WoodAJ: Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.Drug Metab. Dispos.24 , 761\u2013764 (1996).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.9.1125"},{"key":"e_1_3_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.157"},{"key":"e_1_3_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041888"},{"key":"e_1_3_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00191-5"},{"key":"e_1_3_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-008-0299-2"},{"key":"e_1_3_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-2-6530"},{"key":"e_1_3_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200423010-00005"},{"key":"e_1_3_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2008.11.001"},{"key":"e_1_3_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.10.025"},{"key":"e_1_3_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/2001207a0"},{"key":"e_1_3_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00712.x"},{"key":"e_1_3_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1985.tb04065.x"},{"key":"e_1_3_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53003-9"},{"key":"e_1_3_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3430487"},{"key":"e_1_3_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3002(61)90290-6"},{"key":"e_1_3_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)80426-9"},{"key":"e_1_3_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)37472-6"},{"key":"e_1_3_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0114-x"},{"key":"e_1_3_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00965839"},{"key":"e_1_3_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973527"},{"key":"e_1_3_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.03.035"},{"key":"e_1_3_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563651003757954"},{"key":"e_1_3_3_3_117_1","first-page":"91","article-title":"[How expensive must a treatment room be?].","volume":"42","author":"Hetz G","year":"1991","unstructured":"Hetz G : [How expensive must a treatment room be?].Zahnarztl. Prax.42 , 91\u201392 (1991).","journal-title":"Zahnarztl. Prax."},{"key":"e_1_3_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498259109043199"},{"key":"e_1_3_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498259409043299"},{"key":"e_1_3_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.011627"},{"key":"e_1_3_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-009-3441-1"},{"key":"e_1_3_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014191"},{"key":"e_1_3_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200101000-00021"},{"key":"e_1_3_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250701449431"},{"key":"e_1_3_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2001.00344.x"},{"key":"e_1_3_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/88.5.653"},{"key":"e_1_3_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00247.x"},{"key":"e_1_3_3_3_128_1","unstructured":"Rang HP DaleMM RitterJM: Pharmacology 6th Edition. Churchill Livingston London UK 532\u2013533 (2007)."},{"key":"e_1_3_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/77.4.441"},{"key":"e_1_3_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb11031.x"},{"key":"e_1_3_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6888.1340-b"},{"key":"e_1_3_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X0203000323"},{"key":"e_1_3_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9545759.x"},{"key":"e_1_3_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96574910.x"},{"key":"e_1_3_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2010.02491.x"},{"key":"e_1_3_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200081103"},{"key":"e_1_3_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004311-197412020-00018"},{"key":"e_1_3_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.026328"},{"key":"e_1_3_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/29.5.376"},{"key":"e_1_3_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.02.005"},{"key":"e_1_3_3_3_141_1","first-page":"887","article-title":"Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes.","volume":"29","author":"Yanagihara Y","year":"2001","unstructured":"Yanagihara Y , KariyaS, OhtaniM et al.: Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes.Drug Metab. Dispos.29 , 887\u2013890 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.7.853"},{"key":"e_1_3_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100353"},{"key":"e_1_3_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(86)90171-4"},{"key":"e_1_3_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2007.11.002"},{"key":"e_1_3_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2008.09.001"},{"key":"e_1_3_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1058"},{"key":"e_1_3_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1312"},{"key":"e_1_3_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90106-1"},{"key":"e_1_3_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.88"},{"key":"e_1_3_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.87"},{"key":"e_1_3_3_3_152_1","first-page":"557","article-title":"Metabolism of phencyclidine by human liver microsomes.","volume":"25","author":"Laurenzana EM","year":"1997","unstructured":"Laurenzana EM , OwensSM: Metabolism of phencyclidine by human liver microsomes.Drug Metab. Dispos.25 , 557\u2013563 (1997).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_153_1","unstructured":"Cook CE JeffcoatAR Perez-ReyesM: Pharmacokinetic studies of cocaine and phencyclidine in man. In: Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs. Barnett G Chiang CN (Eds). Biomedical Publications Forest City CA USA 48\u201374 (1985)."},{"key":"e_1_3_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.1.46"},{"key":"e_1_3_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx8001302"},{"key":"e_1_3_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.10.024"},{"key":"e_1_3_3_3_157_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.","volume":"270","author":"Shimada T","year":"1994","unstructured":"Shimada T , YamazakiH, MimuraM, InuiY, GuengerichFP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.J. Pharmacol. Exp. Ther.270 , 414\u2013423 (1994).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2007.12.001"},{"key":"e_1_3_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/4501157a"},{"key":"e_1_3_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(97)00175-7"},{"key":"e_1_3_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001"},{"key":"e_1_3_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70038-X"},{"key":"e_1_3_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473710902020157"},{"key":"e_1_3_3_3_164_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054709334505"},{"key":"e_1_3_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ap.34.3.220"},{"key":"e_1_3_3_3_166_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-3565(25)30016-9","article-title":"Metabolism and disposition of methylphenidate-14C: studies in man and animals.","volume":"191","author":"Faraj BA","year":"1974","unstructured":"Faraj BA , IsrailiZH, PerelJM et al.: Metabolism and disposition of methylphenidate-14C: studies in man and animals.J. Pharmacol. Exp. Ther.191 , 535\u2013547 (1974).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00142a021"},{"key":"e_1_3_3_3_168_1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-9556(25)07963-2","article-title":"A study of methylphenidate in man with respect to its major metabolite.","volume":"10","author":"Redalieu E","year":"1982","unstructured":"Redalieu E , BartlettMF, WaldesLM et al.: A study of methylphenidate in man with respect to its major metabolite.Drug Metab. Dispos.10 , 708\u2013709 (1982).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600790602"},{"key":"e_1_3_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.067116"},{"key":"e_1_3_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.11.030"},{"key":"e_1_3_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2010.01.009"},{"key":"e_1_3_3_3_173_1","first-page":"238","article-title":"Influence of ethanol on the pharmacokinetics of methylphenidate\u2018s metabolites ritalinic acid and ethylphenidate.","volume":"60","author":"Koehm M","year":"2010","unstructured":"Koehm M , KauertGF, ToennesSW: Influence of ethanol on the pharmacokinetics of methylphenidate\u2018s metabolites ritalinic acid and ethylphenidate.Arzneimittelforschung60 , 238\u2013244 (2010).","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100082"},{"key":"e_1_3_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2008.04.015"},{"key":"e_1_3_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.04.002"},{"key":"e_1_3_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/452674a"},{"key":"e_1_3_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181cf27d3"},{"key":"e_1_3_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127009903900312"},{"key":"e_1_3_3_3_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00550-1"},{"key":"e_1_3_3_3_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.04.050"},{"key":"e_1_3_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200304000-00009"},{"key":"e_1_3_3_3_183_1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.","volume":"28","author":"Robertson P","year":"2000","unstructured":"Robertson P , DeCoryHH, MadanA, ParkinsonA: In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.Drug Metab. Dispos.28 , 664\u2013671 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_184_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847010-00006"},{"key":"e_1_3_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.09.035"},{"key":"e_1_3_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00059.x"},{"key":"e_1_3_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00574-X"},{"key":"e_1_3_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(99)00189-9"},{"key":"e_1_3_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80530-4"},{"key":"e_1_3_3_3_190_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.7.550"},{"key":"e_1_3_3_3_191_1","first-page":"94","volume":"1","author":"Verstraete AG","year":"1999","unstructured":"Verstraete AG , Van de Velde EJ: 2-oxo-3-hydroxy-LSD: an important LSD metabolite? Acta Clin. Belg. Suppl.1 , 94\u201396 (1999).","journal-title":"Acta Clin. Belg. Suppl."},{"key":"e_1_3_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9028-5"},{"key":"e_1_3_3_3_193_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1994.10472441"},{"key":"e_1_3_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182234399"},{"key":"e_1_3_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.04.001"},{"key":"e_1_3_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.12.041"},{"key":"e_1_3_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.1021\/ol016820d"},{"key":"e_1_3_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20191"},{"key":"e_1_3_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.01.002"},{"key":"e_1_3_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6865(97)00014-9"},{"key":"e_1_3_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1080\/1355621021000005937"},{"key":"e_1_3_3_3_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.01.008"},{"key":"e_1_3_3_3_203_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15014J"},{"key":"e_1_3_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(00)00213-9"},{"key":"e_1_3_3_3_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11419-006-0006-2"},{"key":"e_1_3_3_3_206_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.031138"},{"key":"e_1_3_3_3_207_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0809890"},{"key":"e_1_3_3_3_208_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.1.3"},{"key":"e_1_3_3_3_209_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69248-5_2"},{"key":"e_1_3_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.10.011"},{"key":"e_1_3_3_3_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.02.006"},{"key":"e_1_3_3_3_212_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3679"},{"key":"e_1_3_3_3_213_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.02.011"},{"key":"e_1_3_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.1097\/01213011-200502000-00007"},{"key":"e_1_3_3_3_215_1","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-120015696"},{"key":"e_1_3_3_3_216_1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0022-3565(24)35227-9","article-title":"Ethnic differences in N-glucuronidation of nicotine and cotinine.","volume":"291","author":"Benowitz NL","year":"1999","unstructured":"Benowitz NL , Perez-StableEJ, FongI et al.: Ethnic differences in N-glucuronidation of nicotine and cotinine.J. Pharmacol. Exp. Ther.291 , 1196\u20131203 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_3_217_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.2.152"},{"key":"e_1_3_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.2.108"},{"key":"e_1_3_3_3_219_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm010"},{"key":"e_1_3_3_3_220_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.016568"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.10.171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T19:55:43Z","timestamp":1740945343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.10.171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":220,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.2217\/pgs.10.171"],"URL":"https:\/\/doi.org\/10.2217\/pgs.10.171","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}